168 related articles for article (PubMed ID: 11162319)
1. Stability of adenoviral vectors following catheter delivery.
Tsui LV; Zayek N; Frey D; Mello C; Banik G; Falotico R; McArthur JG
Mol Ther; 2001 Jan; 3(1):122-5. PubMed ID: 11162319
[TBL] [Abstract][Full Text] [Related]
2. Catheter-mediated delivery of adenoviral vectors expressing beta-adrenergic receptor kinase C-terminus inhibits intimal hyperplasia and luminal stenosis in rabbit iliac arteries.
Luo Z; Palasis M; Yamakawa M; Liu LX; Vincent KA; Trudell L; Akita GA; Koch WJ; Cheng SH; Gregory RJ; Jiang C
J Gene Med; 2004 Oct; 6(10):1061-8. PubMed ID: 15386742
[TBL] [Abstract][Full Text] [Related]
3. Biocompatibility of adenoviral vectors in poly(vinyl chloride) tubing catheters with presence or absence of plasticizer di-2-ethylhexyl phthalate.
Bilbao R; Reay DP; Koppanati BM; Clemens PR
J Biomed Mater Res A; 2004 Apr; 69(1):91-6. PubMed ID: 14999755
[TBL] [Abstract][Full Text] [Related]
4. Localized adenovirus gene delivery using antiviral IgG complexation.
Levy RJ; Song C; Tallapragada S; DeFelice S; Hinson JT; Vyavahare N; Connolly J; Ryan K; Li Q
Gene Ther; 2001 May; 8(9):659-67. PubMed ID: 11406760
[TBL] [Abstract][Full Text] [Related]
5. Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-beta type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications.
Chung IM; Ueno H; Pak YK; Kim JW; Choi DH; Shin GJ; Yang WI; Jang Ys
Exp Mol Med; 2002 Sep; 34(4):299-307. PubMed ID: 12515396
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
Zhang J; Frolov I; Russell SJ
J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
[TBL] [Abstract][Full Text] [Related]
7. Pre-treatment with elastase improves the efficiency of percutaneous adenovirus-mediated gene transfer to the arterial media.
Maillard L; Ziol M; Tahlil O; Le Feuvre C; Feldman LJ; Branellec D; Bruneval P; Steg P
Gene Ther; 1998 Aug; 5(8):1023-30. PubMed ID: 10326024
[TBL] [Abstract][Full Text] [Related]
8. Adenoviral vectors for liver-directed gene therapy.
Connelly S
Curr Opin Mol Ther; 1999 Oct; 1(5):565-72. PubMed ID: 11249663
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.
Yoon SK; Armentano D; Wands JR; Mohr L
Cancer Gene Ther; 2001 Aug; 8(8):573-9. PubMed ID: 11571535
[TBL] [Abstract][Full Text] [Related]
10. Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells.
Côté J; Garnier A; Massie B; Kamen A
Biotechnol Bioeng; 1998 Sep; 59(5):567-75. PubMed ID: 10099373
[TBL] [Abstract][Full Text] [Related]
11. Long-term retinal transgene expression with FIV versus adenoviral vectors.
Loewen N; Leske DA; Cameron JD; Chen Y; Whitwam T; Simari RD; Teo WL; Fautsch MP; Poeschla EM; Holmes JM
Mol Vis; 2004 Apr; 10():272-80. PubMed ID: 15094709
[TBL] [Abstract][Full Text] [Related]
12. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors.
Tai KF; Chen PJ; Chen DS; Hwang LH
J Gene Med; 2003 May; 5(5):386-98. PubMed ID: 12731087
[TBL] [Abstract][Full Text] [Related]
13. Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants.
Stachelek SJ; Song C; Alferiev I; Defelice S; Cui X; Connolly JM; Bianco RW; Levy RJ
Gene Ther; 2004 Jan; 11(1):15-24. PubMed ID: 14681693
[TBL] [Abstract][Full Text] [Related]
14. High-capacity 'gutless' adenoviral vectors.
Kochanek S; Schiedner G; Volpers C
Curr Opin Mol Ther; 2001 Oct; 3(5):454-63. PubMed ID: 11699889
[TBL] [Abstract][Full Text] [Related]
15. Efficient in vivo catheter-based pericardial gene transfer mediated by adenoviral vectors.
March KL; Woody M; Mehdi K; Zipes DP; Brantly M; Trapnell BC
Clin Cardiol; 1999 Jan; 22(1 Suppl 1):I23-9. PubMed ID: 9929764
[TBL] [Abstract][Full Text] [Related]
16. Analysis of adenoviral transport mechanisms in the vessel wall and optimization of gene transfer using local delivery catheters.
Palasis M; Luo Z; Barry JJ; Walsh K
Hum Gene Ther; 2000 Jan; 11(2):237-46. PubMed ID: 10680838
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
18. A minimally invasive approach for efficient gene delivery to rodent hearts.
Ding Z; Fach C; Sasse A; Gödecke A; Schrader J
Gene Ther; 2004 Feb; 11(3):260-5. PubMed ID: 14737085
[TBL] [Abstract][Full Text] [Related]
19. Catheter-mediated subselective intracoronary gene delivery to the rabbit heart: introduction of a novel method.
Parsa CJ; Reed RC; Walton GB; Pascal LS; Thompson RB; Petrofski JA; Emani SM; Folgar F; Riel RU; Nicchitta CV; Koch WJ
J Gene Med; 2005 May; 7(5):595-603. PubMed ID: 15651066
[TBL] [Abstract][Full Text] [Related]
20. The controversial role of adenoviral-derived vectors in gene therapy programs: where do we stand?
Romano G
Drug News Perspect; 2006 Mar; 19(2):99-106. PubMed ID: 16628265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
